TRMT112 and pancreatic neoplasm: Interestingly, METTL5 (a methyltransferase that specifically catalyzes 18 S rRNA N6 methylation at adenosine 1832) was considered an oncogene that promoted pancreatic cancer progression synergistically with its cofactor TRMT112 (tRNA methyltransferase activator subunit 11‐2) [21].